Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Tiziana Life Sciences Ltd (TLSA) had Normalized Pre-Tax Income of $-14.98M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-11.86M |
|
-- |
|
-- |
|
$15.79M |
|
$-15.79M |
|
$-0.95M |
|
$-16.75M |
|
|
Normalized Pre-Tax Income |
$-14.98M |
$-11.86M |
|
$-11.86M |
|
$-11.86M |
|
$-9.58M |
|
$-15.79M |
|
$-15.67M |
|
107.84M |
|
107.84M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$7.51M |
|
$0.02M |
|
$3.78M |
|
$11.28M |
|
$7.35M |
|
-- |
|
-- |
|
$7.35M |
|
$3.94M |
|
$3.94M |
|
$3.94M |
|
111.46M |
|
| Cash Flow Statement Financials | |
$-1.53M |
|
$-0.07M |
|
$4.50M |
|
$1.18M |
|
$3.72M |
|
$2.54M |
|
$5.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-301.40% |
|
-301.40% |
|
-105.13% |
|
-301.40% |
|
$0.04 |
|
$-0.01 |
|
$-0.01 |
|